Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $279 | $267 | $442 | $287 |
| Short-Term Investments | $714 | $701 | $564 | $836 |
| Receivables | $1 | $229 | $167 | $125 |
| Inventory | $29 | $36 | $31 | $24 |
| Other Curr. Assets | $219 | $18 | $16 | $12 |
| Total Curr. Assets | $1,242 | $1,250 | $1,219 | $1,284 |
| Property Plant & Equip (Net) | $254 | $234 | $207 | $202 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $201 | $185 | $174 |
| Long-Term Investments | $0 | $0 | $0 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $217 | $6 | $6 | $6 |
| Total NC Assets | $471 | $440 | $397 | $386 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,713 | $1,690 | $1,616 | $1,670 |
| Liabilities | – | – | – | – |
| Payables | $102 | $75 | $58 | $37 |
| Short-Term Debt | $150 | $6 | $5 | $5 |
| Tax Payable | $0 | $12 | $20 | $24 |
| Deferred Revenue | $0 | $34 | $40 | $47 |
| Other Curr. Liab. | $181 | $139 | $111 | $164 |
| Total Curr. Liab. | $434 | $265 | $234 | $278 |
| LT Debt | $260 | $382 | $357 | $346 |
| Deferred Rev, NC | $0 | $7 | $6 | $6 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $8 | $0 | $0 | $0 |
| Total NC Liab. | $268 | $389 | $364 | $352 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $95 | $78 | $57 | $49 |
| Total Liabilities | $702 | $654 | $598 | $630 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,928 | -$1,888 | -$1,763 | -$1,662 |
| AOCI | $201 | $117 | -$7 | -$68 |
| Other Equity | $2,738 | $2,807 | $2,788 | $2,770 |
| Total Equity | $1,011 | $1,036 | $1,018 | $1,041 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,713 | $1,690 | $1,616 | $1,670 |
| Net Debt | $131 | $121 | -$79 | $64 |